Geralyn Messerlian
Brown University
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Geralyn Messerlian.
Obstetrics & Gynecology | 2004
Tuangsit Wataganara; Inga Peter; Geralyn Messerlian; Lynn Borgatta; Diana W. Bianchi
OBJECTIVE: Clinical applications of the analysis of cell-free fetal DNA in maternal plasma and serum are expanding. However, use of fetal DNA during prenatal screening requires knowledge of variables that might affect its levels in the maternal circulation. We conducted this study to estimate the effect of selected demographic factors on fetal DNA levels in the first and second trimesters of pregnancy. METHODS: We developed a database that included fetal DNA levels and clinical information, such as maternal age, ethnicity, weight, and smoking history. We measured fetal DNA levels in maternal plasma and serum using real-time quantitative polymerase chain reaction amplification of a Y chromosome specific sequence. The fetal DNA data from fresh first trimester plasma and previously frozen second trimester serum samples were analyzed separately. Fetal DNA levels were adjusted according to gestational age and storage time and then analyzed in association with the demographic factors. RESULTS: In the first trimester group, no significant association between maternal age, weight, ethnic background, or smoking and plasma fetal DNA levels was observed. In the second trimester group, a significant inverse correlation between maternal weight and serum fetal DNA level was demonstrated (r = −0.26, P = .007). This was especially prominent when the mothers weighed more than 170 lb (P = .001). Maternal age, ethnicity, and smoking were not significantly associated with the second trimester serum fetal DNA levels. CONCLUSION: Fetal DNA levels are affected by maternal weight in the second trimester. A correction for this effect may be needed in larger-scale studies or for future clinical applications that measure cell-free fetal nucleic acids in maternal circulation. LEVEL OF EVIDENCE: II-3
American Journal of Reproductive Immunology | 2015
Rebecca Scherzer; Peter Bacchetti; Geralyn Messerlian; Johanna L. Goderre; Pauline M. Maki; David B. Seifer; Kathryn Anastos; Roksana Karim; Ruth M. Greenblatt
Effects of HIV infection on ovarian function and aging are unclear.
Prenatal Diagnosis | 2015
Glenn E. Palomaki; Elizabeth Eklund; Louis M. Neveux; Geralyn Messerlian
Examine primary Down syndrome screening using combinations of first trimester serum markers, with and without sequencing of cell free DNA as a secondary reflexive test.
Gynecologic Oncology | 2008
Richard G. Moore; Amy K. Brown; M. Craig Miller; Steven J. Skates; W. Jeffrey Allard; Thorsten Verch; Margaret M. Steinhoff; Geralyn Messerlian; Paul DiSilvestro; C.O. Granai; Robert C. Bast
American Journal of Obstetrics and Gynecology | 2002
Thomas Lee; Erik S. LeShane; Geralyn Messerlian; Jacob Canick; Antonio Farina; Walter Heber; Diana W. Bianchi
Human Genetics | 2003
Tuangsit Wataganara; Erik S. LeShane; Antonio Farina; Geralyn Messerlian; Thomas H. Lee; Jacob A. Canick; Diana W. Bianchi
American Journal of Obstetrics and Gynecology | 2005
Jane Cleary-Goldman; Fergal D. Malone; Geralyn Messerlian; Lisa M. Sullivan; Jacob A. Canick; T. Flint Porter; David A. Luthy; Susan Gross; Mary E. D'Alton
Gynecologic Oncology | 2018
A.M. Blackman; M.C. Miller; E. Eklund; R.M. Strongin; Geralyn Messerlian; Richard G. Moore
Gynecologic Oncology | 2017
J.E. Mitchell; M.C. Miller; Rakesh K. Singh; Geralyn Messerlian; Richard G. Moore
European Respiratory Journal | 2013
Hasina Meridia; Geralyn Messerlian; Patrizia Curran; Kristen Butterfield; Ghada Bourjeily